We are live on ! Find out more
GCM

Genus Capital Management Portfolio holdings

AUM $1.02B
1-Year Est. Return 88.73%
This Fund
S&P 500
This Quarter Est. Return
+34.76%
1 Year Est. Return
+88.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.02B
AUM Growth
+$143M
Cap. Flow
-$32.8M
Cap. Flow %
-3.23%
Top 10 Hldgs %
25.91%
Holding
229
New
40
Increased
53
Reduced
84
Closed
25

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$12.2M
2
GLW icon
Corning
GLW
+$10.2M
3
MRK icon
Merck
MRK
+$9.4M
4
GILD icon
Gilead Sciences
GILD
+$9.38M
5
ULTA icon
Ulta Beauty
ULTA
+$8.06M

Sector Composition

Rank Sector Weight
1 Technology 31.42%
2 Financials 18.38%
3 Consumer Discretionary 8.22%
4 Healthcare 7.77%
5 Industrials 7.67%

No holdings matched the selected filter criteria.

Similar funds

Genus Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Genus Capital Management held 229 positions worth $1.02B, up 16% from $873M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Genus Capital Management withdrew a net $32.8M in Q2 2026, closing 25 positions and reducing 84 holdings. Its most notable exit was Ciena, an estimated $5.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Genus Capital Management opened a new position in Cardinal Health worth $9.09M.

  • Genus Capital Management's largest Q2 2026 buy was Cardinal Health: 38,270 shares worth $9.09M.
  • Genus Capital Management added most to eBay in Q2 2026, an estimated $12.7M increase.
  • Genus Capital Management's biggest Q2 2026 reduction was IBM, cutting an estimated $12.2M.
  • Genus Capital Management fully exited Ciena in Q2 2026, selling an estimated $5.44M.
  • Genus Capital Management's ten largest holdings make up 26% of its $1.02B portfolio in Q2 2026.
  • Genus Capital Management opened 40 new positions and closed 25 in Q2 2026.
  • Genus Capital Management's portfolio value rose 16% quarter-over-quarter to $1.02B.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.